FindTrial
Sign In

Evaluation of occupational therapy in reducing psychiatric symptoms in individuals with alzheimer's disease

A randomized controlled trial to evaluate a method of occupational therapy in reducing neuropsychiatric symptoms in individuals with alzheimer's disease

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-66dh44
Enrollment
Unknown
Registered
2017-10-27
Start date
2016-01-18
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dementia, Alzheimer's Disease

Interventions

The study aims to evaluate the effectiveness of an American method of Occupational Therapy which was translated into Portuguese Language and adapted to an outpatient version, with a total of 8 session
Behavioural
E02.831.489
SP5.001.047.133

Sponsors

Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
Lead Sponsor
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
Collaborator

Eligibility

Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: Individuals over the age of 60 with dementia diagnosis provided by a physician responsible for the treatment.; elderly people with scores of Mini Mental State Examination (MMSE) between 10 and 20 at the time of screening; elderly people with the presence of one or more neuropsychiatric symptoms or behavioral; elderly people with caregivers for at least four hours per day

Exclusion criteria

Exclusion criteria: Visual or hearing impairments dysfunctional, or seriously impaired health status, or those who have changed their medications for medical reasons, come to derail the implementation of assistance; Concomitant psychiatric illness such as schizophrenia, bipolar affective disorder, Depressive Disorder Severe or Recurrent and Alcohol and Drug Addiction, in serious condition or outside clinical control; Inability to come to the Hospital for the interventions; Caregiver with MMSE <25

Design outcomes

Primary

MeasureTime frame
Improvement of neuropsychiatric symptoms in individuals with dementia from experimental group identified by the test "Neuropsychiatric Inventory- Clinician version";Reducing of burden caregivers from experimental group identified by Zarit test—

Secondary

MeasureTime frame
Translation to the Portuguese Language and study of inter-interviewer reliability of the Cognitive Battery of Claudia Allen—

Countries

Brazil

Contacts

Public ContactAlexandra de Oliveira

Departamento de Psiquiatria da Faculdade de Medicina da Universidade de São Paulo

xandamartini@uap.br+55 (11) 26618043

Outcome results

None listed

Source: REBEC (via WHO ICTRP)